Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE- Apple, Fedex, Tesla, Dollar Tree, Five Below, Adobe

Wed, 18th Sep 2013 11:58

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)

Sept 18 (Reuters) - Some U.S. stocks to watch on Wednesday:

FUTURES EDGE UP AHEAD OF FED DECISION

U.S. stock index futures edged higher on Wednesday ahead ofan announcement by the Federal Reserve on the future of itseconomic stimulus program.

** APPLE INC, Tuesday close $455.32, up 1 pctpremarket

The fingerprint reader on Apple's top-end iPhone 5S receivedan early thumbs up for ease of use from two influentialreviewers, helping dispel concerns about the scanning technologywhich has been notoriously unreliable in other cellphones.

** FEDEX CORP, Tuesday close $110.68, up 2.2 pctpremarket

Fedex posted a bigger quarterly profit as the couriercompany cut costs and its lower-priced ground shipping businessdid well.

** ADOBE SYSTEMS INC, Tuesday close $48.14, up 6pct premarket

The company, known for its Photoshop and Acrobat software,expects subscriber growth to top the 331,000 it added in thethird quarter due to strong demand from corporate customers.

** DOLLAR TREE INC, Tuesday close $55.83, up 3.5pct after market

The value retailer on Tuesday announced a $2 billion sharerepurchase program. The company also said it had entered intoagreements to repurchase $1 billion of its common shares under avariable maturity accelerated share repurchase program.

** FIVE BELOW INC, Tuesday close $48.5, down 2 pctafter market

The specialty value retailer on Tuesday announced asecondary offering by its shareholders. The company saidshareholders have agreed to sell 7.1 million shares of itscommon stock, of which 7 million shares would be sold by fundsaffiliated with Advent International and 100,000 shares will besold by Five Below's executive chairman.

** NATIONSTAR MORTGAGE HOLDINGS INC, Tuesday close$55.03

Jefferies raised its rating on the residential mortgageservicer's stock to "buy" from "hold", saying that highermortgage rates will lead to improved profitability and itexpects "another round of bulk servicing sales" in late 2013 orearly 2014. It also raised its target price on the stock to $64from $40.

** AON PLC, Tuesday close $70.01, up 2.2 pct aftermarket

Walgreen Co is moving 120,000 employees to the AonHewitt Corporate Health Exchange as part of a growing movementto offer employees cash to purchase their own plans on suchexchanges, the company will announce Wednesday.

** VANTIV INC, Tuesday close $27.25, up 1.1 pctafter market

Evercore raised its price target on the payment processor'sstock to $38 from $33 saying that it expects its net revenue infiscal year 2015 to grow by 12 percent due to higher revenue pertransaction.

** L&L ENERGY INC, Tuesday close $2.23

The U.S. coal miner with operations in China said it waslooking for acquisition opportunities in Northern China to addat least 1 million tons of coal production every year.

** AT&T INC, Tuesday close $34.75

AT&T is planning to announce on Wednesday that it willexpand its Latin American reach for business customers through acollaboration with Mexican billionaire Carlos Slim's AmericaMovil. AT&T will be able to do business in 15countries, including Argentina, Chile and Colombia, throughconnections with America Movil networks, according to arepresentative for AT&T.

** SMITHFIELD FOODS INC, Tuesday close $34.15

China's Shuanghui International is close to securingshareholder approval for its $4.7 billion offer for SmithfieldFoods, which would be the biggest purchase of a U.S. company bya Chinese firm, ahead of the vote next week, three peoplefamiliar with the matter said.

** GLAXOSMITHKLINE PLC , Tuesday close $51.13

A crackdown on corruption in China's pharmaceutical sectorhas hurt sales at international and local firms, with manydoctors at Chinese hospitals refusing to see drugrepresentatives for fear of being caught up in the wideningscandal. Britain's GlaxoSmithKline, the group at the centre ofthe furore, has suffered the most. Industry insiders expect itsChina drug sales growth to slow sharply or even reverse in thethird quarter after a 14 percent year-on-year rise in the threemonths to end-June.

** HONEYWELL INTERNATIONAL INC, Tuesday close $85.45

U.S. regulators on Tuesday ordered airlines to inspect morethan 3,800 planes to ensure that emergency locator beacons soldby Honeywell International do not have battery problems thatcould cause a fire.

** TESLA MOTORS INC, Tuesday close $166.23

Electric car company Tesla Motors is working to produce acar capable of running on "auto-pilot" within the next threeyears, CEO Elon Musk said, joining tech giant Google and rival carmakers in the race to roll a driverless car intothe market.

** PANDORA MEDIA INC, Tuesday close $25.19

The Internet radio company has won a Manhattan federal courtdecision rejecting efforts by some music publishers to narrow alicense that enables the largest U.S. Internet radio service toplay their music. (Compiled by Varun Aggarwal)

More News
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.